Please read this leaflet carefully before you start using TRELEGY ELLIPTA. This leaflet answers some common questions about TRELEGY ELLIPTA. It does not contain all the available information.

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups.

With prices finalized for the first 10 Medicare Part D drugs selected for the initial round of pricing negotiations, attention now turns to the next 15 drugs the U.S. government is eyeing for the ...

Preview: FC Twente Women vs. Chelsea - prediction, team news, lineups Preview: Shrewsbury vs. Exeter - prediction, team news, lineups Preview: Philadelphia 76ers vs. Brooklyn Nets - prediction ...

With CI/CD, Dependabot, and the world’s largest developer community, GitHub gives your team everything they need to ship better software faster. Build the way that works best for you with support for ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...